ARTICLE | Company News
Orexigen jumps ahead of Contrave update
June 2, 2011 12:08 AM UTC
Orexigen Therapeutics Inc. (NASDAQ:OREX) gained $0.51 (18%) to $3.34 on Wednesday after saying it will provide an update on Friday about the NDA for obesity candidate Contrave. Orexigen did not disclose details. ...